Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ASB17061 capsules in adults with atopic dermatitis has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ASB17061

Snippet

Sponsor: Daiichi Sankyo | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2021-02-16